Emergent Biosolutions, Inc. (NYSE: EBS), Johnson & Johnson (NYSE: JNJ) – USA puts Johnson & Johnson in charge of the problem vaccine factory in Baltimore, removes AstraZeneca
Johnson & Johnson will take over the factory after 15 million doses of the Covid-19 vaccine have been spoiled
The FDA will allow the factory to ship the Johnson & Johnson vaccine, which should increase the supply of the single-dose vaccine.